<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="94cb7331-7eb8-412e-b8f5-662d6671332c"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Permethrin Cream, 5%*</title>
   <effectiveTime value="20230131"/>
   <setId root="bdb796aa-a7d1-4476-988f-2b4a9519788f"/>
   <versionNumber value="10"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="600093611" root="1.3.6.1.4.1.519.1"/>
            <name>Padagis Israel Pharmaceuticals Ltd</name>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="2a8cd2d6-0aef-4a97-a85b-23b1aa1e0af0"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20170110"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="45802-269" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Permethrin</name>
                        <formCode code="C28944" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CREAM"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Permethrin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="50"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="509F88P9SZ" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PERMETHRIN</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="509F88P9SZ" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>PERMETHRIN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="1P9D0Z171K" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BUTYLATED HYDROXYTOLUENE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="HHT01ZNK31" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="C9H2L21V7U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>MEDIUM-CHAIN TRIGLYCERIDES</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERIN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="230OU9XXE4" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERYL MONOSTEARATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="0RE8K4LNJS" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ISOPROPYL MYRISTATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="884C3FA9HE" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>LANOLIN ALCOHOLS</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="T5L8T28FGP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>MINERAL OIL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="I835H2IHHX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CETETH-20</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="1HG84L3525" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>FORMALDEHYDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="60"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="45802-269-37" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20060811"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA076369" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20060811"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38304" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TOPICAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="i4i_section_id_484a076c-0977-4d1f-912f-3e30052019ad">
               <id root="324ea13c-2ef6-4693-8f2d-cf9de88819e7"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>*<content styleCode="bold">w/w</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx Only</content>
                  </paragraph>
               </text>
               <effectiveTime value="20151002"/>
            </section>
         </component>
         <component>
            <section ID="i4i_description_id_d205bac6-6d95-4467-80a6-bb846f7d5fbe">
               <id root="7a9c1a53-6466-4d1b-b02e-b8523ea3d036"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Permethrin Cream, 5% is a topical scabicidal agent for the treatment of infestation with <content styleCode="italics">Sarcoptes scabiei</content> (scabies). It is available in an off-white, vanishing cream base. Permethrin Cream, 5% is for topical use only.</paragraph>
                  <renderMultiMedia ID="id12809601" referencedObject="ID_9700c5ab-4291-445f-9432-7ef2f1e6d977"/>
                  <paragraph>
                     <content styleCode="bold">Chemical Name</content> – The permethrin used is an approximate 1:3 mixture of the cis and trans isomers of the pyrethroid 3-(2,2-dichloroethenyl)-2, 2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl) methyl ester. Permethrin has a molecular formula of C<sub>21</sub>H<sub>20</sub>Cl<sub>2</sub>O<sub>3</sub> and a molecular weight of 391.29. It is a yellow to light orange-brown, low melting solid or viscous liquid.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Active Ingredient</content> – Each gram contains permethrin 50 mg (5%).</paragraph>
                  <paragraph>
                     <content styleCode="bold">Inactive Ingredients</content> – Butylated hydroxytoluene, carbomer homopolymer type B, fractionated coconut oil, glycerin, glyceryl monostearate, isopropyl myristate, lanolin alcohols, mineral oil, polyoxyethylene cetyl ethers, purified water, and sodium hydroxide. Formaldehyde 1 mg (0.1%) is added as a preservative.</paragraph>
               </text>
               <effectiveTime value="20220228"/>
               <component>
                  <observationMedia ID="ID_9700c5ab-4291-445f-9432-7ef2f1e6d977">
                     <text>Image 1</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_clinical_pharmacology_id_51c177ed-f9c3-465f-b0d5-3b486ba1b6ce">
               <id root="0275a03c-1e99-c514-7f14-5b873444a940"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Permethrin, a pyrethroid, is active against a broad range of pests including lice, ticks, fleas, mites, and other arthropods. It acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.</paragraph>
                  <paragraph>Permethrin is rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine. Although the amount of permethrin absorbed after a single application of the 5% cream has not been determined precisely, data from studies with <sup>14</sup>C-labeled permethrin and absorption studies of the cream applied to patients with moderate to severe scabies indicate it is 2% or less of the amount applied.</paragraph>
               </text>
               <effectiveTime value="20070105"/>
            </section>
         </component>
         <component>
            <section ID="i4i_indications_id_d314d1bb-c320-43e4-ab31-b329c86fb1f5">
               <id root="9b1830cf-e85f-40ab-b1a4-49994748aad5"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Permethrin Cream, 5% is indicated for the treatment of infestation with <content styleCode="italics">Sarcoptes scabiei</content> (scabies).</paragraph>
               </text>
               <effectiveTime value="20170110"/>
            </section>
         </component>
         <component>
            <section ID="i4i_contraindications_id_9206286c-c043-4e02-8681-51fe3ee91a78">
               <id root="a956286d-d245-4e23-8960-1b21561d2a07"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Permethrin Cream, 5% is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.</paragraph>
               </text>
               <effectiveTime value="20070105"/>
            </section>
         </component>
         <component>
            <section ID="i4i_warnings_id_a207aff4-7f11-4e93-ae7a-d98771fbabf2">
               <id root="19e0dee7-a5f2-40a9-9f26-b1dd477db833"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>If hypersensitivity to Permethrin Cream, 5% occurs, discontinue use.</paragraph>
               </text>
               <effectiveTime value="20070105"/>
            </section>
         </component>
         <component>
            <section ID="i4i_precautions_id_e5295eee-6a67-40ce-a706-47365e3d7752">
               <id root="1b8ac26e-4ce2-4154-a546-17982fd9e79d"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20170110"/>
               <component>
                  <section ID="i4i_precautions_general_id_prec-gen">
                     <id root="e35447df-7680-49b6-a7b0-83be8e1d6b54"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General -</title>
                     <text>
                        <paragraph>Scabies infestation is often accompanied by pruritus, edema, and erythema. Treatment with Permethrin Cream, 5% may temporarily exacerbate these conditions.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_info_patients_id_55a0b4e9-be58-467d-877e-9ead8fefcd81">
                     <id root="4c49c249-5d43-4bfc-95e7-8981c1e88952"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>Information for Patients -</title>
                     <text>
                        <paragraph>Patients with scabies should be advised that itching, mild burning and/or stinging may occur after application of Permethrin Cream, 5%. In clinical trials, approximately 75% of patients treated with permethrin cream, 5% who continued to manifest pruritus at 2 weeks had cessation by 4 weeks. If irritation persists, they should consult their physician. Permethrin Cream, 5% may be very mildly irritating to the eyes. Patients should be advised to avoid contact with eyes during application and to flush with water immediately if Permethrin Cream, 5% gets in the eyes.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_carcinogenesis_mutagenesis_fertility_id_8d2bf8bb-1da8-432a-bd8d-6e91bbc1fce7">
                     <id root="0ea18273-8b19-466b-9bff-ef6d215103fe"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, Mutagenesis, Impairment of Fertility -</title>
                     <text>
                        <paragraph>Six carcinogenicity bioassays were evaluated with permethrin, three each in rats and mice. No tumorigenicity was seen in the rat studies. However, species-specific increases in pulmonary adenomas, a common benign tumor of mice of high spontaneous background incidence, were seen in the three mouse studies. In one of these studies there was an increased incidence of pulmonary alveolar-cell carcinomas and benign liver adenomas only in female mice when permethrin was given in their food at a concentration of 5000 ppm. Mutagenicity assays, which give useful correlative data for interpreting results from carcinogenicity bioassays in rodents, were negative. Permethrin showed no evidence of mutagenic potential in a battery of <content styleCode="italics">in vitro</content> and <content styleCode="italics">in vivo</content> genetic toxicity studies.</paragraph>
                        <paragraph>Permethrin did not have any adverse effect on reproductive function at a dose of 180 mg/kg/day orally in a three-generation rat study.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pregnancy_id_8aab2e01-fb5a-4a86-8ac4-1fd1046b00fa">
                     <id root="d9f0da13-f3f3-483d-a788-cd2adbb9aa76"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy: Teratogenic Effects: Pregnancy Category B - </title>
                     <text>
                        <paragraph>Reproduction studies have been performed in mice, rats, and rabbits (200 to 400 mg/kg/day orally) and have revealed no evidence of impaired fertility or harm to the fetus due to permethrin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20170110"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_nursing_mothers_id_fa8fa16b-2669-4dd2-a3a0-90009cf147c5">
                     <id root="c4ae1a5e-816c-4f31-aed0-dce828da734c"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing Mothers -</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the evidence for tumorigenic potential of permethrin in animal studies, consideration should be given to discontinuing nursing temporarily or withholding the drug while the mother is nursing.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pediatric_use_id_79e48789-a28c-49f2-b6b8-83305394a401">
                     <id root="2e33c628-f1a6-485d-8374-951358b6e097"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use -</title>
                     <text>
                        <paragraph>Permethrin Cream, 5% is safe and effective in pediatric patients two months of age and older. Safety and effectiveness in infants less than two months of age have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_geriatric_use_id_836ca667-9c4b-4e7e-af2b-67396293f5e9">
                     <id root="1715c974-7c5b-403b-992d-b63fec650b78"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>Geriatric Use -</title>
                     <text>
                        <paragraph>Clinical studies of permethrin cream, 5% did not identify sufficient numbers of subjects aged 65 and over to allow a definitive statement regarding whether elderly subjects respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. This drug is known to be substantially excreted by the kidney. However, since topical permethrin is metabolized in the liver and excreted in the urine as inactive metabolites, there does not appear to be an increased risk of toxic reactions in patients with impaired renal function when used as labeled.</paragraph>
                     </text>
                     <effectiveTime value="20121129"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_adverse_effects_id_570f3b24-0ed7-44ac-bbc1-caf26ac4eb67">
               <id root="482484ee-b0bc-47a8-8c1a-2455a46cb35a"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>In clinical trials, generally mild and transient burning and stinging followed application with permethrin cream, 5% in 10% of patients and was associated with the severity of infestation. Pruritus was reported in 7% of patients at various times post-application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients (see <content styleCode="bold">PRECAUTIONS-General</content>). Other adverse events reported since marketing permethrin cream, 5% include: headache, fever, dizziness, abdominal pain, diarrhea and nausea and/or vomiting. Although extremely uncommon and not expected when used as directed (see <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>), rare occurrences of seizure have been reported. None have been medically confirmed as associated with Permethrin Cream, 5% treatment.</paragraph>
               </text>
               <effectiveTime value="20220228"/>
            </section>
         </component>
         <component>
            <section ID="i4i_overdosage_id_77b58022-9a54-4789-98ca-f816bdc36001">
               <id root="be0357a1-f285-4228-9208-947304c8eef3"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>No instance of accidental ingestion of Permethrin Cream, 5% has been reported. If ingested, gastric lavage and general supportive measures should be employed. Excessive topical use (see <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>) may result in increased irritation and erythema.</paragraph>
               </text>
               <effectiveTime value="20151002"/>
            </section>
         </component>
         <component>
            <section ID="ID_5a4340df-919a-4b49-896e-48b7c9a73c22">
               <id root="7d56d6ab-45c4-493c-94aa-80627ff1cb05"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <effectiveTime value="20220228"/>
               <component>
                  <section ID="ID_1fe1d100-008f-4996-b391-4df0c622b8c9">
                     <id root="cdde24f7-ea4f-46e7-9bc1-a375b9203b63"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Adults and children – </title>
                     <text>
                        <paragraph>Thoroughly massage Permethrin Cream, 5% into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. <content styleCode="bold">ONE APPLICATION IS GENERALLY CURATIVE</content>. </paragraph>
                        <paragraph>Patients may experience persistent pruritus after treatment. This is rarely a sign of treatment failure and is not an indication for retreatment. Demonstrable living mites after 14 days indicate that retreatment is necessary.</paragraph>
                     </text>
                     <effectiveTime value="20220228"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_how_supplied_id_acd068fa-1b1e-40d2-876e-75643f2b1d00">
               <id root="2df2df5f-0c84-49c3-815a-c808bbf9aea7"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Permethrin Cream, 5% (w/w) is available as follows: </paragraph>
                  <paragraph>60 g tube (NDC 45802-<content styleCode="bold">269</content>-37)</paragraph>
               </text>
               <effectiveTime value="20070105"/>
            </section>
         </component>
         <component>
            <section ID="i4i_storage_id_6d3dcce5-96ae-4176-b002-1ad9b01b6351">
               <id root="0ee6dab3-7e27-4cdf-a49e-d1bd09d93150"/>
               <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
               <title>STORAGE</title>
               <text>
                  <paragraph>Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].</paragraph>
                  <paragraph>Manufactured By Padagis<br/>Yeruham, Israel</paragraph>
                  <paragraph>Distributed By<br/>Padagis <br/>Allegan, MI 49010 <br/>www.padagis.com</paragraph>
                  <paragraph>Rev 01-23</paragraph>
                  <paragraph>77L00 RC PH1</paragraph>
               </text>
               <effectiveTime value="20230131"/>
            </section>
         </component>
         <component>
            <section ID="i4i_Principal_display_panel_id_08eee77c-f204-4791-a9cc-a81b2ba80914">
               <id root="1c27213b-7a09-43b3-b745-6377de05d710"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Principal Display Panel</title>
               <text>
                  <paragraph>NDC 45802-269-37</paragraph>
                  <paragraph>Rx Only</paragraph>
                  <paragraph>Permethrin Cream, 5%*</paragraph>
                  <paragraph>For External Use Only.  Not for Use In Eyes.</paragraph>
                  <paragraph>NET WT 60 g </paragraph>
                  <paragraph>*w/w</paragraph>
                  <renderMultiMedia ID="id864938584" referencedObject="ID_901d14ea-398d-4ba7-8ee2-8b84d6b4137c"/>
                  <paragraph>The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.</paragraph>
                  <renderMultiMedia ID="id-266921440" referencedObject="D09FDBEC-E740-4769-9813-2C64311875A0"/>
               </text>
               <effectiveTime value="20230131"/>
               <component>
                  <observationMedia ID="ID_901d14ea-398d-4ba7-8ee2-8b84d6b4137c">
                     <text>Permethrin Cream, 5% carton image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="77l96rcc1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D09FDBEC-E740-4769-9813-2C64311875A0">
                     <text>serialization-template.jpg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="serialization-template.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>